SEC Form 4 · accession 0001246360-17-001320
NxStage Medical, Inc. · NXTM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Winifred L Swan
Officer — SVP and General Counsel
Period of report
Mar 9, 2017
Accepted (ET)
Mar 13, 2017 · 6:28 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001333170
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $27.89 | Mar 9, 2017 | A | 39,884 | A | Apr 9, 2017 | Mar 8, 2027 | Common Stock | 39,884 | 39,884 | D |
Explanation of responses
- F1The stock option becomes exercisable in 48 equal monthly installments beginning April 9, 2017.